0001171843-18-000444.txt : 20180118 0001171843-18-000444.hdr.sgml : 20180118 20180118171759 ACCESSION NUMBER: 0001171843-18-000444 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180117 FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toner E. Scott CENTRAL INDEX KEY: 0001643772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 18534738 MAIL ADDRESS: STREET 1: 25 PIER 7 CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2018-01-17 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001643772 Toner E. Scott C/O PROTEON THERAPEUTICS 200 WEST STREET WALTHAM MA 02451 0 1 0 0 Senior VP of Commercial Stock Option (Right to Buy) 2.85 2018-01-17 4 A 0 110000 0 A 2028-01-16 Common Stock, $0.001 par value 110000 110000 D The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. /s/ George A. Eldridge as attorney-in-fact 2018-01-18